---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-006160"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:38:46.317444+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# United-Guardian Q3 net income up to $0.19/share; nine-month sales +17%

## Summary
- Nine-month 2024 sales $9.7M (+17% YoY); net income $2.7M ($0.60/share) vs $1.8M ($0.40/share) in 2023.
- Q3 sales steady at $3.06M; net income $865K ($0.19/share) up from $627K ($0.14/share).
- Cosmetic ingredient sales surged 68% in nine months, driven by largest distributor.
- Medical lubricant sales +4% over nine months; pharmaceutical sales -11% due to Renacidin supply disruption.
- President expects continued recovery from Renacidin supply shutdown.

## SEC filing metadata
- accession: 0001171843-24-006160
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184324006160/0001171843-24-006160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184324006160/f8k_110724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-006160
- JSON: https://secwatch.observer/filing/0001171843-24-006160.json
- Plain text: https://secwatch.observer/filing/0001171843-24-006160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.